Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +1.51% | -2.58% |
02-02 | Novozymes, Chr. Hansen Complete Merger Settlement | MT |
02-02 | Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Nordic All-Share Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.58% | 10.52B | - | ||
-5.67% | 27.45B | B- | ||
+18.78% | 24.56B | B | ||
+5.34% | 11.01B | B- | ||
+11.49% | 5.11B | C- | ||
+14.97% | 4.33B | B+ | ||
-13.08% | 3.62B | C | ||
-5.98% | 2.8B | C+ | ||
+25.30% | 2.75B | C+ | ||
-5.32% | 2.17B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- CHR Stock
- 51C Stock
- Ratings Christian Hansen